This study describes the results of testing 92 serum samples, including 10 umbilical cord serum samples, from 38 cytomegalovirus (CMV)-infected neonates for CMV-specific immunoglobulin E (IgE) and M by antibody-capture enzyme-linked immunosorbent assays with enzyme-labeled CMV antigen. All (19) , making serological diagnosis difficult. However, infants also produce antibodies of the IgE class (9). This antibody class does not pass from mother to fetus and is short-lived. Recently, in a study of patients of whom most were immunocompromised transplant recipients or had hematological malignancies, van Loon et al. (21) found that specific antibodies of the IgE class occur during primary CMV infection but not during recurrent infection. We found it of interest to examine whether specific IgE antibodies are also produced in neonatal CMV infection and to compare the results with a study of the CMV IgM response by antibodycapture ELISAs with enzyme-labeled CMV antigen. As shown in this study, the CMV IgE antibody-capture ELISA is more sensitive than the IgM antibody-capture ELISA for detection of CMV antibodies in infants. In consequence, the method is now included among the tests used in our laboratory for routine diagnosis of CMV infections.
Infections with cytomegalovirus (CMV) are relatively common among infants, although only a small proportion of infected neonates show symptoms typical of CMV disease (1, 2; K. Ahlfors, Ph.D. thesis, University of Lund, Malmo, Sweden, 1982) . The infection may be either congenital or acquired, often resulting from transmission of the virus from the mother to the infant. Intrauterine transmission can occur at any time during gestation, but most infants are probably infected during birth or from the mother's milk. In developed industrial countries, the rate of congenitally CMV-infected infants is about 0.5%, whereas about 20% of infants acquire CMV infection during their first year of life (1, 2, 5, 8, 18 ; Ahlfors, Ph.D. thesis).
The most sensitive method of diagnosing CMV infection in neonates is isolation of virus from urine. Testing for antibodies may be hampered by the transmission of CMV antibodies of the immunoglobulin G (IgG) class from seropositive mothers to offspring. On the other hand, infected infants may themselves produce CMV antibodies of the IgM class. During the last decade several reports have appeared on the detection of CMV IgM antibodies by an immunofluorescence test, radioimmunoassay, and enzymelinked immunosorbent assay (ELISA) (10, 17, 19) . These indirect techniques, which use CMV antigen fixed to a solid phase and a flùorescein-, isotope-, or enzyme-coupled antiIgM antibody, are of less value, because Rh factors and CMV IgG antibodies may interfere with the reactions. Therefore, sera have to be either fractionated or absorbed before use in the indirect IgM antibody tests (11) . Recently, IgM antibody-capture methods for diagnosing CMV infections have been described as reliable, sensitive, and easy to perform (16, 20 (19) , making serological diagnosis difficult. However, infants also produce antibodies of the IgE class (9) . This antibody class does not pass from mother to fetus and is short-lived. Recently, in a study of patients of whom most were immunocompromised transplant recipients or had hematological malignancies, van Loon et al. (21) found that specific antibodies of the IgE class occur during primary CMV infection but not during recurrent infection. We found it of interest to examine whether specific IgE antibodies are also produced in neonatal CMV infection and to compare the results with a study of the CMV IgM response by antibodycapture ELISAs with enzyme-labeled CMV antigen. As shown in this study, the CMV IgE antibody-capture ELISA is more sensitive than the IgM antibody-capture ELISA for detection of CMV antibodies in infants. In consequence, the method is now included among the tests used in our laboratory for routine diagnosis of CMV infections.
MATERIALS AND METHODS
Patients and controls. In connection with the diagnostic service and a prospective study of the incidence of congenital CMV infection (1), we collected 92 serum samples from 38 CMV-infected infants. CMV was in all cases isolated from the urine within the first 4 months of life. Serum specimens were usually available about the time that CMV excretion was detected, but in two infants with symptoms of congenital CMV infection at birth the first serum sample was taken 6 weeks before demonstration of CMV excretion. Ten of the sera were umbilical cord sera. The patients consisted of two groups: (i) 17 infants who were found to excrete CMV within the first week of life and (ii) 21 excrete CMV between the first week and the fourth month of life. The infants in the first group were infected in utero, whereas the second group probably contained both congenitally infected infants and infants with acquired CMV infection, one case of which occurred after blood transfusion.
Controls included 46 neonates less than 4 months old from whom CMV was not isolated from urine after a single attempt. The control sera were obtained within 2 weeks before or after attempted virus isolation. Eighteen of the sera were umbilical cord sera. Complement-fixing (CF) antibodies to CMV in titers from 4 to 64 were demonstrated in 31 (67%) of the 46 control sera.
Due to the ethical problems involved in obtaining blood samples from sick infants, we never requested follow-up sera after demonstration of CMV excretion, but in some cases clinicians sent additional sera. The number of serum samples studied from the 38 cases were as follows: one from 14 infants, two from 11, three from 3, four from 6, and five from 3. The interval between consecutive samples in each case was at least 14 days. From one infant eight samples, covering the period from birth to 12 months of age, were studied. All sera were inactivated at 56°C for 0.5 h and kept frozen at -20°C until use.
Diagnostic methods. Methods for isolating CMV in human lung cell (HEL) cultures and determination of CF antibodies have been published previously (1) . Virus isolation was performed in glass flasks containing 50 cm2 of HEL monolayers, which were inoculated with 0.5 ml of urine diluted with 0.5 ml of cell culture medium, and the pH was adjusted to 7.2 by dropwise addition of 2.8% sodium bicarbonate solution. The mixture was adsorbed to the cell cultures for 1 h at 37°C and afterwards exchanged with 20 ml of medium. Viruses were identified as CMV by their slowly developing cytopathic effect, resulting in production of plaques in cell culture. The number of small plaques was counted after staining with methylene blue in a colony counter (magnification, 20x) before the development of secondary plaques (ordinarily 2 weeks after the first observation of microscopic plaques), and the number of plaques was subsequently used for estimation of the virus excretion titer (PFU per milliliter of urine).
Antigens. CMV antigen was prepared from nuclei of HEL cells infected with the Ad-169 strain of human CMV essentially as reported previously (12, 20, 21) . Briefly, when nearly complete cytopathic effect was observed, cells were trypsin dispersed and suspended in hypotonic buffer at 0°C for 30 min. Nonidet P-40 was added, and the cells were disrupted in a tight-fitting Dounce homogenizer. When the nuclei were largely freed from the cytoplasm, the suspension was sedimented by centrifugation, and the pellet was suspended in cold phosphate-buffered saline (PBS). The nuclei were separated from cellular debris by centrifugation (1, 200 x g for 15 min at 4°C) through a layer of 17% Ficoll 400 in PBS. The pellet was suspended in 0.01 M sodium carbonate buffer (pH 9.5). The suspension was sonicated and clarified by centrifugation (5,000 x g for 10 min). The supernatant was used as the antigen for enzyme labeling. Control antigen was prepared from the nuclei of uninfected HEL cells by the same procedure.
Antigen labeling procedure. The CMV and control antigens were labeled with horseradish peroxidase by the periodate method essentially as described earlier (12, 20, 21) the antibodies. Later sera were available for three of these negative cases, but none became positive for CMV antibodies in either the IgM or IgE class.
Of the 10 umbilical cord sera included in this material ( Fig.  1), 6 were CMV IgE positive, 5 also contained CMV IgM antibodies, and 4 were completely negative.
Statistical analysis by Wilcoxon's rank sum test for the 31 sera containing one or both antibodies revealed that the CMV-specific IgE absorbance was significantly higher (P < 0.0001) than the CMV-specific IgM absorbance.
CMV IgM and IgE in sera from non-CMV-excreting infants. The results for the 46 control sera for CMV-specific IgM and IgE antibodies are also shown in Fig. 1 . Forty-three (93%) were negative for both antibody classes. Sera from two infants, however, were slightly positive for CMV IgE antibodies only, and one infant was positive for both. Of these three infants, one was CF seronegative (titer, <4), and two had CMV CF antibodies with titers of 4 and 32. All 18 control umbilical cord serum samples were negative.
CMV IgM and IgE in later samples from infants excreting CMV. The remaining material, from infants up to 24 months of age, was also tested for CMV-specific IgM and IgE, and in this material too, the CMV IgE test was the most sensitive. The results for 92 serum samples covering the period from 0 to 24 months of age are given in Table 1 . Of the 92 sera, 76 contained either CMV IgM, CMV IgE, or both. Sixteen sera (17%) were positive only for CMV IgE, and one serum was positive only for CMV IgM. In 69 (91%) of the 76 sera, the reactivity of CMV IgE was higher than the reactivity of CMV IgM antibodies, and this phenomenon was independent of age ( Table 1 ). The number of sera which were negative for CMV antibodies of both classes increased with age, as 43% of the sera from infants more than 6 months of age were negative for antibodies of either class. Total IgE in infants excreting CMV. Twenty-four serum samples from seven of the CMV-excreting infants were tested for total IgE (data not shown). Sera were taken from 1 day to 6 month of age. Two of the infants had only a very slight CMV IgE antibody response, whereas the remaining five infants were clearly positive for CMV IgE. The level of total IgE in the 24 sera was between <0.23 and 18.4 ,ug/liter. According to the standard for this age group, none of the infants had elevated levels of total IgE (4, 9) .
Relationship between CMV IgM and IgE antibody reactivity and level of virus excretion. The results of analyzing whether there was any correlation between the presence and reactivity of the two antibody classes and the antigen burden, as determined by CMV excretion level, appear in Fig. 2 . No correlation was found by comparing either the initial specimens from the infants (Fig. 2) or the antibody reactivity of the two classes in later blood specimens with later virus excretion levels (data not shown). DISCUSSION This study demonstrates the results of testing sera from 38 CMV-infected neonates for both IgE and IgM antibodies to CMV by antibody-capture ELISAs.
Surprisingly, the reactivity of specific IgE antibodies, expressed as absorbance, was found to be higher than the specific IgM response in about 90% of the positive sera from CMV-infected infants (Table 1) . This was especially unexpected because the total amounts of these immunoglobulin classes are so different, the level of IgM during the first 6 months of life being on the order of 1.1 to 4.3 g/liter and the level of IgE being between .2.3 and 25 ,ug/liter (9) .
The advantage of including a test for CMV antibodies of the IgE class in the diagnosis of CMV infection in neonates is best illustrated in the study of the initial samples (Fig. 1) . Of the 38 sera from infants excreting CMV, 25 were positive in both tests, whereas 6 sera contained CMV IgE antibodies only. Thus, by using the IgE test, a serological diagnosis was possible for 82%, whereas with the IgM test alone a serological diagnosis of the infection would only have been possible for 66%.
It would have been more simple just to replace the test for IgM antibodies with the test for IgE antibodies, but as seen in Fig. 1 , this is not advisable, as one sample had higher reactivity in the IgM than in the IgE test. Moreover, one of the late sera was IgM positive but IgE negative.
With increasing age there is a tendency in these earlyinfected infants to a decrease in both classes of antibodies, as 43% of the sera taken after the age of 6 months were negative in both tests ( Table 1) . None of the sera tested reacted against the control conju- It is generally accepted (10) that the most sensitive diagnostic test for congenitally and neonatally acquired CMV infection is isolation of CMV from urine. This, however, is a time-consuming and cumbersome test demanding cell cultures. Furthermore, isolation of CMV is not a 100% efficient test, as CMV may only be intermittently present in the urine of infected infants (7) . In this respect, it is interesting that three (7%) of our control infants who were found not to be excreting CMV showed positive reactions in one or both tests (Fig. 1) . This was probably not because of nonspecific reactions, as no reaction was observed with the control conjugate. It was probably also not a question of persistence of maternal IgG antibodies, as only two of them were CMV CF positive, with titers of 4 and 32, titers which were also found among 67% of the CMV IgE-and IgM-negative control infants. These infants were most likely infected, although CMV by chance was not detected in the urine.
Why is the specific reactivity higher in the IgE test than in the IgM test? First, the cutoff level in the IgM test is twice as high as that in the IgE test because the reactivity of control sera with CMV conjugate is higher in the IgM test. We have tried to reduce the background by different methods, but it has not been possible to get below 0.2 for the cutoff level of the IgM test, a level which is comparable to that found by others (15, 16, 19, 20) . Thus, some of the increased sensitivity in the IgE test is attributable to the difference in the backgrounds in the two tests. Secorid, it seems in some cases to be a question of relatively higher amounts of specific IgE than of IgM antibodies, as the reactivity of nine sera was considerably higher in the IgE than in the IgM test. We have no explanation for these individual variations, but they do not seem to depend on the antigenic burden, as evaluated by virus excretion levels (Fig. 2) . Neither does it seem to be a question of stability of the two classes of antibodies at -20°C, as specific antibodies of both antibody classes were detectable in sera after storage for up to 10 years.
Certain viral infections are known to produce specific IgE antibody, to the extent that significant changes in the level of total serum IgE may occur (3, (13) (14) (15) 22) . However, although we controlled the level of total IgE in serum for some of our patients when sufficient amounts of serum were available, the level did not in any case exceed the levels normally found in infants of the same age (4, 9) .
The conclusion of this study is that detection of CMV IgE and IgM antibodies by antibody-capture ELISA is a sensitive and specific means of diagnosing CMV infection in neonates. Detection of CMV IgE in particular is of great value. The specific CMV IgE response can probably also be demonstrated by other sensitive techniques (ELISA, radioimmunoassay). In addition, detection of specific IgE probably will be of great value in the diagnosis of other congenital infectious diseases (15) . We have not yet investigated these possibilities.
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